e-learning
resources
European Respiratory Review
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How to detect disease progression in pulmonary arterial hypertension
Vachiéry J-L., Yerly P., Huez S.
Source:
Eur Respir Rev 2012; 21: 40-47
Journal Issue:
March 2012 - 21 (123)
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vachiéry J-L., Yerly P., Huez S.. How to detect disease progression in pulmonary arterial hypertension. Eur Respir Rev 2012; 21: 40-47
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
The study of risk in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:234-238
Year: 2012
The burden of pulmonary hypertension
Source: Annual Congress 2006 - The burden of pulmonary hypertension
Year: 2006
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012
Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Novel treatment for pulmonary vascular disease: lessons from pathophysiology
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Bosentan for sarcoidosis associated pulmonary arterial hypertension (BoSAPH) was effective in advanced parenchymal lung disease
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012
Severe pulmonary hypertension in lung disease: phenotypes and response to treatment
Source: Eur Respir J 2015; 46: 1378-1389
Year: 2015
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012
Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Newly diagnosed patients with chronic thromboembolic pulmonary hypertension and PASP<50 mmHg. Do they need pulmonary endarterectomy?
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
Treatment of pulmonary hypertension in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept